Johnson & Johnson has halved the size of its collaboration with Bavarian Nordic on vaccines…
A new “black cheque” company that claims to be the first in Europe devoted to…
A study has shown that a mobile game can be used to gather symptom data…
The PING Conference 2022 is back in person this year, with opportunities to network face-to-face…
Throughout my 30-year career, there have been many times it was obvious I stood out…
Sanofi has completed the spin-out of its pharma ingredients business EuroAPI, with shares in the…
Biogen has licensed rights to a digital therapeutic (DTx) developed by MedRhythms which combines sensors,…
A digital therapeutic (DTx) developed to help people suffering from insomnia has been shown to…
Novartis has shut down production of its radioligand therapies – one of its key growth…
Forget the number of deaths worldwide from COVID-19 estimated by the various trackers of around…
Sidekick Health is already working with pharma heavyweights Pfizer and Bayer on gamified apps that…
Curebase has raised $40 million in second-round financing that will help it run more complex…
Preparation and practice are potent forces in sales but they form a golden triangle when…
After a long period of not much change, clinical trials are undergoing several massive shifts.…
AstraZeneca’s SGLT2 inhibitor Farxiga has hit the mark in a phase 3 heart failure trial…
SAE Media Group’s 3rd AnnualWearable Injectors and Connected Devices Conference10 – 11 October 2022 |…
Assuring end-patient safety through holistic contamination control Sponsored by: Associates of Cape Cod, Bioscience International…
Three years after it was formed as spinout of Japanese drugmaker Takeda, Phathom Pharmaceuticals has…
A quick recap: Who are CDISC and what do they do? The Clinical Data Interchange Standards…
The US FDA has authorised a new test that can detect amyloid plaques in early-stage…
This post was originally published on Source Link
Novartis’ CAR-T Kymriah has become the first therapy in the category to be approved for…
Testing drug compounds on a chip designed to mimic human organs sounds closer to science…
Cognitive problems affecting memory and attention can be substantial and long-lasting in patients who suffer…
Hello Heart has raised $70 million in fourth-round financing to help grow its smartphone-based technology…
SAE Media Group’s 3rd Annual ConferencePre-Filled Syringes San FranciscoSeptember 19 – 20, 2022 | San…
With TCEs being studied in both hematological and solid tumors (39 and 34 trials respectively),…
Biogen has announced a major revamp of its business that will see chief executive Michel…
Alain Labrique, PhD, professor and associate chair of research at Johns Hopkins Bloomberg School of…
Idorsia has become the first drugmaker in the EU to claim approval for a drug…
Israeli cancer diagnosis startup Imagene AI has raised $21.5 million in first-round financing for its…
Gilead Sciences has made another foray into the natural killer (NK) cell category, paying $300…
A scientist working in Switzerland has become the fifth person to be convicted of attempting…
The FDA has declined to approve two more cancer therapies developed by drugmakers based in…
In the latest episode of the pharmaphorum podcast, editor in chief Jonah Comstock speaks with…
AstraZeneca has revealed plans to set up a new strategic R&D hub in Cambridge, Massachusetts…
Oliver Stohlmann’s Corporate Survival Hacks series draws on his experiences of working in local, regional…
For many patients with type 2 diabetes, having to inject basal insulin every day is…
An artificial intelligence-powered digital tool for diagnosing skin cancers developed by Skin Analytics has been…
Bristol-Myers Squibb’s has become the first company to bring a cardiac myosin inhibitor through to…
Orders for Merck & Co’s oral antiviral for COVID-19 helped to swell the drugmaker’s first…
Rare diseases aren’t as rare as the appellation suggests. For instance, according to the US…
Harness Safe & Efficacious Lipid-Based Delivery for Novel Therapeutics Beyond RNA & Hepatic Tissue The…
Denmark’s Novo Nordisk has been almost single-handedly rebuilding the market for drugs to treat obesity…
OMass Therapeutics has raised an impressive $100 million in a Series B financing that is…
Vifor Pharma and Cara Therapeutics’ Kapruvia has become the first drug to be approved in…
Abbott has joined forces with two other companies to bring an automated insulin delivery (AID)…
Pfizer’s $1.2 billion licensing deal with Biohaven for rights to oral migraine drug rimegepant is…
Trust in life science companies has fluctuated since the start of the pandemic. The reputation…